← Browse by Condition
Medical Condition

psoriatic arthritis

Total Trials
9
Recruiting Now
9
Trial Phases
Phase 2, Phase 1

ClinicalMetric tracks all active clinical trials for psoriatic arthritis sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — psoriatic arthritis Clinical Trials

How many clinical trials are currently recruiting for psoriatic arthritis?
ClinicalMetric currently tracks 9 actively recruiting clinical trials for psoriatic arthritis, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 9. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for psoriatic arthritis?
psoriatic arthritis research spans Phase 1 (1 trial), Phase 2 (2 trials). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a psoriatic arthritis clinical trial?
Eligibility criteria for psoriatic arthritis trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 1
1
Phase 2
2
Top Sponsors
University of California, San Diego 1 trial
Universitätsklinikum Hamburg-Eppendorf 1 trial
University Hospital, Lille 1 trial
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. 1 trial
Novartis Pharmaceuticals 1 trial

Recruiting Clinical Trials

NCT06586281
Recruiting
Elucidating Shared Mechanisms Contributing to NAFLD and PsA Disease Severity With Guselkumab Therapy
Enrollment
20 pts
Location
United States
Sponsor
University of California, San ...
View Trial →
NCT01848028
Recruiting
PsoBest - The German Psoriasis Registry
Enrollment
3,500 pts
Location
Germany
Sponsor
Universitätsklinikum Hamburg-E...
View Trial →
NCT04334031
Recruiting
Deployment o the Multidisciplinary Prospective Cohort Imminent
Enrollment
2,200 pts
Location
France
Sponsor
University Hospital, Lille
View Trial →
NCT07406035 Phase 2
Recruiting
A Clinical Trial of TQH3906 Capsules in the Treatment of Active Psoriatic Arthritis
Enrollment
156 pts
Location
China
Sponsor
Chia Tai Tianqing Pharmaceutic...
View Trial →
NCT06382051
Recruiting
Modifying PEST for Psoriatic Arthritis Screening
Enrollment
502 pts
Location
Canada
Sponsor
Novartis Pharmaceuticals
View Trial →
NCT05858528
Recruiting
HIPPOCRATES Prospective Observational Study
Enrollment
25,000 pts
Location
United Kingdom
Sponsor
University of Oxford
View Trial →
NCT06730334
Recruiting
Prospective Study of Classification and Activity Assessment of Psoriatic Arthritis Based on Power Doppler (PD) Ultrasonography (PDUS)
Enrollment
400 pts
Location
China
Sponsor
Nanjing Medical University
View Trial →
NCT04924270 Phase 2
Recruiting
Safety and Efficacy of Capsule FMT in Treatment-naïve Patients With Newly Diagnosed Chronic Inflammatory Diseases
Enrollment
200 pts
Location
Denmark
Sponsor
Odense University Hospital
View Trial →
NCT03816345 Phase 1
Recruiting
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
Enrollment
300 pts
Location
United States, Canad...
Sponsor
National Cancer Institute (NCI...
View Trial →

Related Conditions

psoriasis (3) multiple sclerosis (2) rheumatoid arthritis (2) crohn disease (2) ulcerative colitis (2) chronic inflammatory disease (1) angioedema (1) severe asthma (1) lupus (1) atopic dermatitis (1) systemic sclerosis (1) beh et disease (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology